Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

MSD

MSD logoMSD is a leading research-driven global healthcare company working to address unmet health needs through the development, manufacturing and distribution of pharmaceuticals.

 

Peter Shaw 

Peter Shaw is Head of Infectious Diseases and Vaccines, Clinical Pharmacogenetics Strategy and Science at Merck & Co., Inc., Kenilworth, NJ, USA.  He has over 15 years experience in the pharmaceutical industry and a keen interest in the strategic development and implementation of biomarkers and genomic platforms throughout drug development. 

In this section

The Bio-medical Research Council (BRC), a part of the Oxford Hospital Radcliffe Trust (OHRT), funds research and many of our staff are involved in BRC research.

Our research is funded from a variety of funders. Their support allows our research to focus on the basic and clinical research domains to accelerate knowledge translation from the bedside to the bench, and back again.